About Zero Point Five Therapeutics
Zero Point Five Therapeutics is a private company based in Baltimore, Maryland. It has reported $11,519,937 raised in two offerings on Form D since July 2023. Its chief executive is Joseph Amprey III.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 2, 2025 | Apr 17, 2025 | $4,299,420of $5.3M target | 10 | $429K | EquityRule 506(b) | Form D ↗ |
| Jun 27, 2023 | Jul 12, 2023 | $7,220,517of $10.1M target | 15 | $481K | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $11,519,937 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Zero Point Five Therapeutics's Form D filed Apr 17, 2025.